Formulation

Curia to acquire Integrity Bio

13-Jul-2021 By Rachel Arthur

Curia, a contract research development and manufacturing organization, will acquire Californian formulation and fill-finish organization Integrity Bio.

Single cell formulation set-up to ‘efficiently deliver RNA vaccines’

29-Jan-2019 By Maggie Lynch

Dolomite’s high throughput, single cell encapsulation set-up aims to accelerate delivery of RNA vaccines.

Amgen enters licensing agreement to use oral formulation platform

18-Dec-2018 By Maggie Lynch

Entera will use its proprietary drug delivery platform to progress Amgen’s preclinical programs into oral formulations.

Health Canada approves subcutaneous treatment for breast cancer

26-Sep-2018 By Maggie Lynch

Halozyme Therapeutics announced that a subcutaneous formulation of trastuzumab created with Halozyme’s technology, for the treatment of breast cancer, has received approval from Health Canada.